The Evolving Role of Immunotherapy and Radiotherapy in the Non-operative Management of Esophageal and Rectal Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: closed (15 October 2023) | Viewed by 3198
Special Issue Editors
Interests: esophageal cancer; proton radiotherapy; SBRT
Special Issues, Collections and Topics in MDPI journals
Interests: rectal cancer; non-operative management; normal tissue toxicity
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue welcomes original research that may be preclinical, translational, or clinical regarding radiotherapy or immunotherapy (or preferably both) in the non-operative management of rectal and esophageal cancers. Submissions may also focus on methods of disease surveillance post-therapy, molecular/clinical predictors of response, normal tissue toxicity, and novel treatment strategies to overcome therapeutic resistance. Topics including novel therapeutic agents or interventions for decreasing normal tissue toxicity of either immunotherapy or radiotherapy for esophageal or rectal cancer, as well as predictors of normal tissue toxicity, will also be acceptable. Studies examining the dose, fractionation, and timing of radiotherapy combined with immunotherapy and their differing effects on tumor cell immune evasion, the tumor microenvironment, or pro-inflammatory signaling cascades will also be welcomed. Submissions concerning novel techniques that correlate radiomics and/or pathology with clinical outcomes of radioimmunotherapy in rectal or esophageal cancer are encouraged as well.
We look forward to receiving your contributions.
Dr. Christopher L. Hallemeier
Dr. Krishan R. Jethwa
Dr. Cameron M. Callaghan
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- radiotherapy
- immunotherapy
- non-operative management
- esophageal cancer
- rectal cancer
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
